Healthcare & Life Sciences
Apoxis
Switzerland
acquiredacquired
acquired
Stage
About
Apoxis was a Swiss company focused on discovering and developing therapeutics targeting cell death, inflammation, and angiogenesis for treating cancer and autoimmune diseases before merging with TopoTarget A/S.
Explore Apoxis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.